Finally, it was found that C-FLIP knockdown restored osimertinib-induced apoptosis in resistant cells (Table 1), suggesting that C-FLIP depletion may be an effective strategy to overcome osimertinib resistance in NSCLC (44, 111). The gene discussed is CFLAR; the disease is non-small cell lung carcinoma.